Literature Review of Hemadsorption Therapy in Severe COVID-19 Cases: a Narrative Review

Koc S., UYSAL H.

CLINICAL LABORATORY, vol.68, pp.401-409, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 68
  • Publication Date: 2022
  • Doi Number: 10.7754/clin.lab.2021.210839
  • Journal Name: CLINICAL LABORATORY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.401-409
  • Keywords: COVID-19, severe coronavirus infection, hemoperfusion, hemadsorption, CytoSorb, cytokine storm, cytokine release syndrome, INFLUENZA-A H7N9, PLASMA-EXCHANGE, HEMOPERFUSION, PATIENT
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background: A novel therapy for reducing the cytokines in the circulatory system used for severe COVID-19 cases was hemoperfusion or hemadsorption method. Although the hemoperfusion methods have been shown to be bene-ficial in the cytokine storm during influenza infection, it is not known to what extent it is successful for COVID-19 patients. Therefore, the purpose of this study is to review the studies on severe COVID-19 treated with the hemo-perfusion methods.